3Narahara Y, Kanazawa H, Fukuda T, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: aprospectiverandomizedtrial. J Gastroenterol, 2011,46 : 78-85.
5Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylenecovered stent grafts. Am J Gastroenterol, 2008,103 : 2738-2746.
6Zervos EE,Rosemurgy AS. Management of medically refractoryascite. Am J Surg,2004,181:256-264.
8Seo YS, Jung ES, An H, et al. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int, 2009, 29: 1521 -1527.
10Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology, 2005, 41:1282 -1289.
